TRUBRIDGE INC (TBRG) Stock Fundamental Analysis
USA - NASDAQ:TBRG - US2053061030 - Common Stock
19.79 USD
+0.02 (+0.1%)
19.79 USD
0 (0%)
Taking everything into account, TBRG scores 4 out of 10 in our fundamental rating. TBRG was compared to 35 industry peers in the Health Care Technology industry. While TBRG is still in line with the averages on profitability rating, there are concerns on its financial health. TBRG is valued quite cheap, while showing a decent growth score. This is a good combination!
1. Profitability
1.1 Basic Checks
TBRG had positive earnings in the past year.
In the past year TBRG had a positive cash flow from operations.
In multiple years TBRG reported negative net income over the last 5 years.
In the past 5 years TBRG always reported a positive cash flow from operatings.
1.2 Ratios
TBRG has a Return On Assets of -2.41%. This is in the better half of the industry: TBRG outperforms 74.29% of its industry peers.
Looking at the Return On Equity, with a value of -5.43%, TBRG is in the better half of the industry, outperforming 74.29% of the companies in the same industry.
TBRG's Return On Invested Capital of 5.32% is amongst the best of the industry. TBRG outperforms 85.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.41% | ||
| ROE | -5.43% | ||
| ROIC | 5.32% |
ROA(3y)-3.89%
ROA(5y)-0.55%
ROE(3y)-9.64%
ROE(5y)-2.79%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
TBRG has a better Operating Margin (6.59%) than 77.14% of its industry peers.
In the last couple of years the Operating Margin of TBRG has declined.
TBRG's Gross Margin of 52.76% is on the low side compared to the rest of the industry. TBRG is outperformed by 60.00% of its industry peers.
In the last couple of years the Gross Margin of TBRG has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.59% | ||
| PM (TTM) | N/A | ||
| GM | 52.76% |
OM growth 3Y-40.35%
OM growth 5Y-26.39%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.4%
GM growth 5Y-0.64%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TBRG is destroying value.
The number of shares outstanding for TBRG has been increased compared to 1 year ago.
TBRG has more shares outstanding than it did 5 years ago.
TBRG has a better debt/assets ratio than last year.
2.2 Solvency
TBRG has an Altman-Z score of 1.99. This is not the best score and indicates that TBRG is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.99, TBRG is in the better half of the industry, outperforming 62.86% of the companies in the same industry.
TBRG has a debt to FCF ratio of 10.13. This is a negative value and a sign of low solvency as TBRG would need 10.13 years to pay back of all of its debts.
TBRG has a Debt to FCF ratio (10.13) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.94 indicates that TBRG is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.94, TBRG is doing worse than 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.94 | ||
| Debt/FCF | 10.13 | ||
| Altman-Z | 1.99 |
ROIC/WACC0.48
WACC11.03%
2.3 Liquidity
TBRG has a Current Ratio of 1.80. This is a normal value and indicates that TBRG is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of TBRG (1.80) is worse than 65.71% of its industry peers.
A Quick Ratio of 1.79 indicates that TBRG should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.79, TBRG is not doing good in the industry: 65.71% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.8 | ||
| Quick Ratio | 1.79 |
3. Growth
3.1 Past
The earnings per share for TBRG have decreased strongly by -36.21% in the last year.
The earnings per share for TBRG have been decreasing by -40.46% on average. This is quite bad
TBRG shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -17.20%.
Measured over the past years, TBRG shows a small growth in Revenue. The Revenue has been growing by 4.53% on average per year.
EPS 1Y (TTM)-36.21%
EPS 3Y-58.61%
EPS 5Y-40.46%
EPS Q2Q%237.5%
Revenue 1Y (TTM)-17.2%
Revenue growth 3Y6.89%
Revenue growth 5Y4.53%
Sales Q2Q%1.18%
3.2 Future
The Earnings Per Share is expected to grow by 132.46% on average over the next years. This is a very strong growth
Based on estimates for the next years, TBRG will show a small growth in Revenue. The Revenue will grow by 3.80% on average per year.
EPS Next Y966.97%
EPS Next 2Y247.16%
EPS Next 3Y132.46%
EPS Next 5YN/A
Revenue Next Year3.3%
Revenue Next 2Y3.82%
Revenue Next 3Y3.8%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 26.74, TBRG can be considered very expensive at the moment.
TBRG's Price/Earnings ratio is rather cheap when compared to the industry. TBRG is cheaper than 82.86% of the companies in the same industry.
TBRG is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.35, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 8.64, which indicates a very decent valuation of TBRG.
Compared to the rest of the industry, the Price/Forward Earnings ratio of TBRG indicates a rather cheap valuation: TBRG is cheaper than 97.14% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of TBRG to the average of the S&P500 Index (22.86), we can say TBRG is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.74 | ||
| Fwd PE | 8.64 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, TBRG is valued cheaply inside the industry as 94.29% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of TBRG indicates a rather cheap valuation: TBRG is cheaper than 88.57% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.12 | ||
| EV/EBITDA | 9.17 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as TBRG's earnings are expected to grow with 132.46% in the coming years.
PEG (NY)0.03
PEG (5Y)N/A
EPS Next 2Y247.16%
EPS Next 3Y132.46%
5. Dividend
5.1 Amount
No dividends for TBRG!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
19.79
+0.02 (+0.1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners69.25%
Inst Owner Change0%
Ins Owners3.16%
Ins Owner Change-1.41%
Market Cap297.05M
Analysts78
Price Target25.25 (27.59%)
Short Float %6.08%
Short Ratio6.18
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)71.79%
Min EPS beat(2)20.66%
Max EPS beat(2)122.91%
EPS beat(4)2
Avg EPS beat(4)-29.99%
Min EPS beat(4)-176.25%
Max EPS beat(4)122.91%
EPS beat(8)5
Avg EPS beat(8)-12.21%
EPS beat(12)6
Avg EPS beat(12)-13.47%
EPS beat(16)8
Avg EPS beat(16)-8.87%
Revenue beat(2)0
Avg Revenue beat(2)-2.06%
Min Revenue beat(2)-3.3%
Max Revenue beat(2)-0.83%
Revenue beat(4)1
Avg Revenue beat(4)-0.86%
Min Revenue beat(4)-3.3%
Max Revenue beat(4)1.51%
Revenue beat(8)2
Avg Revenue beat(8)-1.27%
Revenue beat(12)2
Avg Revenue beat(12)-1.3%
Revenue beat(16)5
Avg Revenue beat(16)-0.61%
PT rev (1m)0%
PT rev (3m)-15.38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)37.23%
EPS NY rev (1m)0%
EPS NY rev (3m)48.32%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.82%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.69%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.74 | ||
| Fwd PE | 8.64 | ||
| P/S | 0.85 | ||
| P/FCF | 18.12 | ||
| P/OCF | 8.51 | ||
| P/B | 1.72 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.17 |
EPS(TTM)0.74
EY3.74%
EPS(NY)2.29
Fwd EY11.57%
FCF(TTM)1.09
FCFY5.52%
OCF(TTM)2.33
OCFY11.76%
SpS23.16
BVpS11.54
TBVpS-7.55
PEG (NY)0.03
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.41% | ||
| ROE | -5.43% | ||
| ROCE | 6.74% | ||
| ROIC | 5.32% | ||
| ROICexc | 5.52% | ||
| ROICexgc | 43.92% | ||
| OM | 6.59% | ||
| PM (TTM) | N/A | ||
| GM | 52.76% | ||
| FCFM | 4.72% |
ROA(3y)-3.89%
ROA(5y)-0.55%
ROE(3y)-9.64%
ROE(5y)-2.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-34.77%
ROICexcg growth 5Y-16.72%
ROICexc growth 3Y-36.47%
ROICexc growth 5Y-24.96%
OM growth 3Y-40.35%
OM growth 5Y-26.39%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.4%
GM growth 5Y-0.64%
F-Score7
Asset Turnover0.89
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.94 | ||
| Debt/FCF | 10.13 | ||
| Debt/EBITDA | 3.32 | ||
| Cap/Depr | 70.69% | ||
| Cap/Sales | 5.33% | ||
| Interest Coverage | 1.58 | ||
| Cash Conversion | 71.1% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.8 | ||
| Quick Ratio | 1.79 | ||
| Altman-Z | 1.99 |
F-Score7
WACC11.03%
ROIC/WACC0.48
Cap/Depr(3y)79.13%
Cap/Depr(5y)69.66%
Cap/Sales(3y)6.13%
Cap/Sales(5y)4.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36.21%
EPS 3Y-58.61%
EPS 5Y-40.46%
EPS Q2Q%237.5%
EPS Next Y966.97%
EPS Next 2Y247.16%
EPS Next 3Y132.46%
EPS Next 5YN/A
Revenue 1Y (TTM)-17.2%
Revenue growth 3Y6.89%
Revenue growth 5Y4.53%
Sales Q2Q%1.18%
Revenue Next Year3.3%
Revenue Next 2Y3.82%
Revenue Next 3Y3.8%
Revenue Next 5YN/A
EBIT growth 1Y256.08%
EBIT growth 3Y-36.24%
EBIT growth 5Y-23.05%
EBIT Next Year156.04%
EBIT Next 3Y43.12%
EBIT Next 5YN/A
FCF growth 1Y2208.59%
FCF growth 3Y-29.73%
FCF growth 5Y-20.85%
OCF growth 1Y48.79%
OCF growth 3Y-12.4%
OCF growth 5Y-5.94%